Viridian Therapeutics, Inc. (VRDN) Revenue Growth
Viridian Therapeutics, Inc. (VRDN) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 15.13% |
| 2018-12-31 | 109.49% |
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | 182.19% |
| 2022-12-31 | -40.20% |
| 2023-12-31 | -82.28% |
| 2024-12-31 | -3.82% |
| 2025-12-31 | 23359.93% |
How VRDN compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| IDYA | IDEAYA Biosciences Inc. | 3024.43% |
| NMTC | NeuroOne Medical Technologies Corporation | 163.47% |
| ETON | Eton Pharmaceuticals Inc. | 104.94% |
| TGTX | TG Therapeutics Inc. | 87.32% |
| TXMD | TherapeuticsMD Inc. | 71.61% |
These are five companies in the same sector as VRDN with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Viridian Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("VRDN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | VRDN | $23.08 | -3.35% | 0.78M |
| 3 | ||||
| 4 | ||||
| 5 |